Startups

Novel proprietary platform for cytokine-based therapies.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 61

Locations

Company Size

  • 1 - 11

Last Stage Round

Industry

Insights

Orikine Bio, based in Barcelona, stands out with its focus on cytokine-based therapies. Using a B2B business model, it targets advanced biological treatments, differentiating itself from conventional pharmaceutical approaches. This innovation could accelerate medical advancements and provide new treatment options where traditional methods have stalled. Backed by investors like AdBio Partners and Asabys Partners, Orikine Bio is well-positioned to leverage its proprietary technologies for significant strides in health care, offering competitive advantages and growth prospects.

Total Funding
$6.2M

Investors

Full Company Profile